Association between human papillomavirus particle production and the severity of recurrent respiratory papillomatosis

被引:3
|
作者
Yamada, Satoshi [1 ,2 ]
Itoh, Toshiya [2 ,3 ]
Ikegami, Taro [4 ]
Imai, Atsushi [1 ]
Mochizuki, Daiki [1 ]
Nakanishi, Hiroshi [1 ]
Ishikawa, Ryuji [1 ]
Kita, Junya [1 ]
Nakamura, Yuki [1 ]
Takizawa, Yoshinori [1 ]
Okamura, Jun [5 ]
Noda, Yoshihiro [6 ]
Iwashita, Toshihide [7 ]
Hariyama, Takahiko [2 ]
Suzuki, Mikio [4 ]
Misawa, Kiyoshi [1 ]
Kawasaki, Hideya [2 ,7 ]
机构
[1] Hamamatsu Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, 1-20-1 Handayama Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[2] Hamamatsu Univ, Preeminent Med Photon Educ & Res Ctr Inst NanoSui, Sch Med, 1-20-1 Handayama Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan
[3] Hamamatsu Univ, Dept Obstet & Gynecol, Sch Med, Hamamatsu, Shizuoka, Japan
[4] Univ Ryukyus, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Okinawa, Japan
[5] Seirei Hamamatsu Gen Hosp, Dept Otorhinolaryngol, Hamamatsu, Shizuoka, Japan
[6] Seirei Mikatahara Gen Hosp, Dept Otorhinolaryngol, Hamamatsu, Shizuoka, Japan
[7] Hamamatsu Univ, Dept Regenerat & Infect Pathol, Sch Med, Hamamatsu, Shizuoka, Japan
基金
日本学术振兴会;
关键词
MALIGNANT-TRANSFORMATION;
D O I
10.1038/s41598-023-32486-8
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recurrent respiratory papillomatosis (RRP) has a wide range of severity. We investigate the relationship between human papillomavirus (HPV) particle production and severity of RRP. From September 2005 to June 2021, 68 RRP samples (from 29 patients) were included. HPV type was determined. HPV viral load, physical status, and demographic and clinical characteristics were assessed. Immunohistochemistry (IHC) was performed for p16, Ki-67, L1, and E4. We used NanoSuit-CLEM (correlative light and electron microscopy) and transmission electron microscopy (TEM) to examine the samples. The total number of surgeries in HPV-positive and HPV-negative cases were 3.78 (n=55/68, range: 1-16) and 1.30 (n=13/68, range: 1-3), respectively (p=0.02). IHC showed that L1 and E4 were correlated and expressed on the tumour surface. NanoSuit-CLEM and TEM revealed HPV particles in L1-positive nuclei. L1 IHC-positive cases had a shorter surgical interval (p<0.01) and more frequent surgeries (p=0.04). P16 IHC, viral load, and physical status were not associated with disease severity. This study visualised HPV particle production in RRP for the first time. Persistent HPV particle infection was associated with severity. We suggest L1 IHC for evaluating RRP severity in addition to the Derkay score.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Differences in Transcriptional Activity of Human Papillomavirus Type 6 Molecular Variants in Recurrent Respiratory Papillomatosis
    do Bonfim, Caroline Measso
    Sobrinho, Joao Simao
    Nogueira, Rodrigo Lacerda
    Kupper, Daniel Salgado
    Pereira Valera, Fabiana Cardoso
    Nogueira, Maurcio Lacerda
    Villa, Luisa Lina
    Rahal, Paula
    Sichero, Laura
    [J]. PLOS ONE, 2015, 10 (07): : e0132325
  • [22] Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis A Nonrandomized Clinical Trial
    Smahelova, Jana
    Hamsikova, Eva
    Ludvikova, Viera
    Vydrova, Jitka
    Traboulsi, Joseph
    Vencalek, Ondrej
    Lukes, Petr
    Tachezy, Ruth
    [J]. JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2022, 148 (07) : 654 - 661
  • [23] Association of Asthma With Clinically Aggressive Recurrent Respiratory Papillomatosis
    Robb, Philip K., Jr.
    Weinberger, Paul M.
    Perakis, Helen
    Li, Anya
    Klein, Adam M.
    Johns, Michael M., III
    Adkins, Lacey K.
    Postma, Gregory N.
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2011, 137 (04) : 368 - 372
  • [24] Human papillomavirus-11-associated recurrent respiratory papillomatosis is more aggressive than human papillomavirus-6-associated disease
    Rabah, R
    Lancaster, WD
    Thomas, R
    Gregoire, L
    [J]. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 2001, 4 (01) : 68 - 72
  • [25] Forecasting Disease Burden with a Dynamic Transmission Model of Human Papillomavirus and Recurrent Respiratory Papillomatosis in the United States
    Palmer, Cody
    Morais, Edith
    Tota, Joseph
    [J]. VIRUSES-BASEL, 2024, 16 (08):
  • [26] Therapeutic Use of the Human Papillomavirus Vaccine on Recurrent Respiratory Papillomatosis: A Systematic Review and Meta-Analysis
    Rosenberg, Tine
    Philipsen, Bahareh B.
    Mehlum, Camilla S.
    Dyrvig, Anne-Kirstine
    Wehberg, Sonja
    Chirila, Magdalena
    Godballe, Christian
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2019, 219 (07): : 1016 - 1025
  • [27] Juvenile-Onset Recurrent Respiratory Papillomatosis: The Benefits of Quadrivalent Human Papillomavirus Vaccination Continue to Accrue
    Donovan, Basil
    Callander, Denton
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (02): : 177 - 178
  • [28] Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and-11
    Bonagura, Vincent R.
    Hatam, Lynda J.
    Rosenthal, David W.
    De Voti, James A.
    Lam, Fung
    Steinberg, Bettie M.
    Abramson, Allan L.
    [J]. APMIS, 2010, 118 (6-7) : 455 - 470
  • [29] The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination
    Chesson, Harrell W.
    Forhan, Sara E.
    Gottlieb, Sami L.
    Markowitz, Lauri E.
    [J]. VACCINE, 2008, 26 (35) : 4513 - 4518
  • [30] Do human papillomavirus vaccines have any role in newborns and the prevention of recurrent respiratory papillomatosis in children?
    Schaffer, Andrea
    Brotherton, Julia
    Booy, Robert
    [J]. JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 2007, 43 (09) : 579 - 580